A single-center analysis of lung transplantation outcomes in recipients aged 70 or older

医学 倾向得分匹配 单中心 内科学 对数秩检验 肺移植 回顾性队列研究 外科 生存分析 移植
作者
Mohammed A. Kashem,Hannah Calvelli,Michael Warnick,Hiromu Kehara,Vipin Dulam,Huaqing Zhao,Roh Yanigada,Norihisa Shigemura,Yoshiya Toyoda
出处
期刊:European Journal of Cardio-Thoracic Surgery [Oxford University Press]
卷期号:65 (6)
标识
DOI:10.1093/ejcts/ezae150
摘要

Abstract OBJECTIVES As life expectancies continue to increase, a greater proportion of older patients will require lung transplants (LTs). However, there are no well-defined age cutoffs for which LT can be performed safely. At our high-volume LT centre, we explored outcomes for LT recipients ≥70 vs <70 years old. METHODS This is a retrospective single-centre study of survival after LT among older recipients. Data were stratified by recipient age (≥70 vs <70 years old) and procedure type (single versus double LT). Demographics and clinical variables were compared using Chi-square test and 2 sample t-test. Survival was assessed by Kaplan–Meier curves and compared by log-rank test with propensity score matching. RESULTS A total of 988 LTs were performed at our centre over 10 years, including 289 LTs in patients ≥70 years old and 699 LTs in patients <70 years old. The recipient groups differed significantly by race (P < 0.0001), sex (P = 0.003) and disease aetiology (P < 0.0001). Older patients were less likely to receive a double LT compared to younger patients (P < 0.0001) and had lower rates of intraoperative cardiopulmonary bypass (P = 0.019) and shorter length of stay (P = 0.001). Both groups had overall high 1-year survival (85.8% vs 89.1%, respectively). Survival did not differ between groups after propensity matching (P = 0.15). CONCLUSIONS Our data showed high survival for older and younger LT recipients. There were no statistically significant differences observed in survival between the groups after propensity matching, however, a trend in favour of younger patients was observed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lio发布了新的文献求助10
1秒前
2秒前
2秒前
凝子老师发布了新的文献求助10
3秒前
白瓜完成签到 ,获得积分10
3秒前
123完成签到,获得积分10
5秒前
5秒前
斯文钢笔完成签到 ,获得积分10
6秒前
Hh发布了新的文献求助10
7秒前
司马天寿发布了新的文献求助10
8秒前
上官若男应助lio采纳,获得10
8秒前
wsnice应助呼呼采纳,获得20
10秒前
科研通AI5应助善良的路灯采纳,获得10
10秒前
12秒前
司马天寿完成签到,获得积分20
14秒前
14秒前
汤圆完成签到,获得积分10
15秒前
bitahu发布了新的文献求助10
15秒前
希望天下0贩的0应助lixm采纳,获得10
15秒前
科研通AI2S应助敦敦采纳,获得10
16秒前
17秒前
_呱_应助楼台杏花琴弦采纳,获得50
18秒前
咸鱼一号发布了新的文献求助10
18秒前
正经俠发布了新的文献求助10
18秒前
李志远完成签到,获得积分10
19秒前
ghh发布了新的文献求助10
19秒前
20秒前
77paocai完成签到,获得积分10
21秒前
CCL完成签到,获得积分10
22秒前
明亮的绫完成签到 ,获得积分10
22秒前
祖诗云完成签到,获得积分0
23秒前
jiewen发布了新的文献求助10
25秒前
25秒前
Oz完成签到,获得积分10
25秒前
zhukun发布了新的文献求助10
26秒前
26秒前
29秒前
香蕉觅云应助oliver501采纳,获得10
29秒前
正经俠完成签到 ,获得积分20
30秒前
YY完成签到 ,获得积分10
31秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
Luis Lacasa - Sobre esto y aquello 700
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527998
求助须知:如何正确求助?哪些是违规求助? 3108225
关于积分的说明 9288086
捐赠科研通 2805889
什么是DOI,文献DOI怎么找? 1540195
邀请新用户注册赠送积分活动 716950
科研通“疑难数据库(出版商)”最低求助积分说明 709849